In a CRISPR-Cas9 mouse model mutating the cleavage site of the (P)RR such that s(P)RR is not generated, the loss of s(P)RR attenuated Ang II induced hypertension while also reducing albuminuria and renal tubular injury [42]. This evidence concerns the gene AGT and hypertensive disorder.